Disrupting this binding or reducing the level of Rab23 has a significant impact on the expression and nuclear localization of Gli1 in human liver cancer cell line Hep3B and HepG2, ultimately leading to suppression of cell growth. The gene discussed is RAB23; the disease is liver cancer.